A woman was transported to the hospital after she was wounded in a shooting outside in a residential area in North Chicago ...

The insurers are looking to disrupt Big Pharma's model of distributing drugs. One of them's even offering to give them to ...

Northbrook has agreed to buy a 2-acre residential site for nearly $1 million for use as a fire station and a center providing ...

AbbVie (NYSE: ABBV) will announce its third-quarter 2024 financial results on Wednesday, October 30, 2024, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 ...

Taste of Chicago, a Chi-town-style pizza and sandwich shop that's served Addison for over a decade, is closing its doors at ...

Chicago police are looking for three males who attacked a man with a knife earlier this month downtown on North Michigan ...

AbbVie has announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ...

Leerink Partners analyst David Risinger has maintained their neutral stance on ABBV stock, giving a Hold rating on September 13. David ...

AbbVie on Friday said the application covers telisotuzumab vedotin, or teliso-V, in adults with previously treated, locally advanced or metastatic epidermal growth factor receptor wild type, ...

AbbVie (NYSE: ABBV) today announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for accelerated approval of telisotuzumab vedotin (Teliso-V) in ...

AbbVie said tavapadon met the primary endpoint in the pivotal Phase 3 fixed-dose monotherapy trial, showing a statistically significant improvement in certain measures of the disease from baseline ...